Effective Treatment of an Orthotopic Xenograft Model of Human Glioblastoma Using an EGFR-retargeted Oncolytic Herpes Simplex VirusHiroaki Uchida, Joseph C. Glorioso, Marco Marzulli et al.|Molecular Therapy|2012Cited by 117
Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicityYoshitaka Miyagawa, Joseph C. Glorioso, Pietro Marino et al.|Proceedings of the National Academy of Sciences|2015Cited by 79
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivityJennifer L. Leddon, Timothy P. Cripe, Joseph C. Glorioso et al.|Molecular Therapy — Oncolytics|2014Cited by 44
The Therapeutic Effects of Gene Therapy with Replication-Deficient Herpes Simplex Virus (HSV) Vectors Encoding Poreless TRPV1 or Protein Phosphate 1α (PP1α) on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen PeroxideShun Takai, Naoki Yoshimura, Tsuyoshi Majima et al.|Neurourology and Urodynamics|2016Cited by 1